Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03769194
Brief Title: Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.

First Submitted : December 6, 2018
First Submitted that Met QC Criteria : December 6, 2018
First Posted : December 7, 2018

Last Update Submitted that Met QC Criteria : September 30, 2019
Last Update Posted : October 1, 2019